Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The latest update on the study of lenvatinib and pembrolizumab for advanced melanoma includes detailed definitions and methodologies for evaluating objective response rate, progression-free survival, and duration of response, along with the reporting of adverse events, following the recent posting of results on October 9, 2024.
    Difference
    30%
    Check dated 2024-10-10T14:31:50.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-10-03T05:07:42.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has been updated to version v2.11.0, with new results submitted, while the previous version v2.10.5 has been removed along with a notice about delays in study record information.
    Difference
    0.9%
    Check dated 2024-09-25T22:46:44.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    0.8%
    Check dated 2024-09-18T16:45:04.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T04:57:30.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-13T23:16:59.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.